How does postop opioid prescribing in the US compare to the rest of the world? How might this information change our practice as med-peds physicians?
What are ACEs and why do they matter? What categories of childhood exposures did the ACE study incorporate? What can we do to prevent ACEs?
Should we treat patients with a target dose or a target LDL level? How often is it helpful to check lipid levels? For primary and secondary prevention, when should we think about using PCSK9 inhibitors, omega-3 fatty acids, niacin, or fibrates?
Just how common is primary aldosteronism anyway? Is an aldosterone-renin ratio the best screening test for primary aldosteronism, or is it something else? How often should we think about screening?